Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study

BACKGROUND: The results of a randomised trial showed the safety and efficacy of Gam-COVID-Vac against COVID-19. However, compared to other vaccines used across the globe, the real-world data on the effectiveness of Gam-COVID-Vac, especially against the disease caused by the Delta variant of concern,...

Descripción completa

Detalles Bibliográficos
Autores principales: Barchuk, Anton, Cherkashin, Mikhail, Bulina, Anna, Berezina, Natalia, Rakova, Tatyana, Kuplevatskaya, Darya, Stanevich, Oksana, Skougarevskiy, Dmitriy, Okhotin, Artemiy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484844/
https://www.ncbi.nlm.nih.gov/pubmed/36123681
http://dx.doi.org/10.1186/s12916-022-02509-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484844/
https://www.ncbi.nlm.nih.gov/pubmed/36123681
http://dx.doi.org/10.1186/s12916-022-02509-8

Ejemplares similares